By Catherine Eckford (European Pharmaceutical Review)2025-03-28T16:20:00
Addressing key challenges in the pharmaceutical and biotechnology environmental monitoring market, such as high technology costs, while leveraging key market drivers is critical for the sector to thrive, analysis suggests.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-29T14:00:00Z 2026-04-29T15:00:00Z
Sponsored by USP
2025-06-11T13:00:00
Sponsored by Rapid Micro Biosystems
2026-04-29T14:00:00 2026-04-29T15:00:00
Sponsored by USP
2026-04-16T15:00:00 2026-04-16T16:00:00
Sponsored by Thermo Fisher Scientific
2025-12-03T07:58:01
Sponsored by MBV AG
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, By European Pharmaceutical Review
Site powered by Webvision Cloud